Health technology


The chronic disease care ‘platform’ continues among digital health companies and Nasdaq-traded Dario Health ($ DRIO) acquired TWO different startups in 2021 alone to increase their core diabetes management offering and keep pace. WayForward and Upright are now under the Dario Health banner and CEO Erez Raphael reveals the strategy behind the two buyouts – which cost the company roughly $ 30 million each and will add digital behavioral health and health to the Dario experience. musculoskeletal care for chronic pain. .

Erez believes the promise of digital health and digital therapy is hyper-personalization, and treating multiple conditions at the same time, in seamless integration, is the way to deliver this valuable accessory. But he is not alone. Teladoc’s Livongo, Vida Health, One Drop, and Omada Health are well-funded competitors that are making the same promise of integrated virtual care. So how will Dario Health stand out? Erez highlights the company’s beginnings in direct-to-consumer sales and its technological expertise as differentiators – will that be enough in the crowded U.S. market with employers and health plans OR is the total addressable market? important enough for Dario to take a significant part in it? We discuss the chronic healthcare market penetration strategy with one of its few publicly traded digital health companies.

Leave a Reply

Your email address will not be published. Required fields are marked *